Arthritis drug stalls RSV growth in cells, hinting at a new antiviral path
In a laboratory study, the inexpensive anti-inflammatory drug indomethacin reduced replication of respiratory syncytial virus (RSV) in human airway cells after infection, while aspirin showed no effect, suggesting a potential antiviral angle but not yet clinical evidence and requiring more research before RSV treatment use.